BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frapard T, Hue S, Rial C, Prost N, Mekontso Dessap A. Antiphospholipid Autoantibodies and Thrombosis in Patients With COVID‐19: Comment on the Article by Bertin et al. Arthritis Rheumatol 2021;73:897-9. [DOI: 10.1002/art.41634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Serrano M, Espinosa G, Serrano A, Cervera R. Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy. Int J Mol Sci 2022;23:4946. [PMID: 35563337 DOI: 10.3390/ijms23094946] [Reference Citation Analysis]
2 Foret T, Dufrost V, Salomon Du Mont L, Costa P, Lefevre B, Lacolley P, Regnault V, Zuily S, Wahl D. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders? Curr Rheumatol Rep 2021;23:65. [PMID: 34218350 DOI: 10.1007/s11926-021-01029-3] [Reference Citation Analysis]
3 Cimolai N. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19. SN Compr Clin Med 2021;:1-16. [PMID: 34179695 DOI: 10.1007/s42399-021-00992-3] [Reference Citation Analysis]
4 Favaloro EJ, Henry BM, Lippi G. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? Semin Thromb Hemost 2021. [PMID: 34130340 DOI: 10.1055/s-0041-1728832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pavoni V, Gianesello L, Horton A. Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon? J Thromb Thrombolysis 2021. [PMID: 33973157 DOI: 10.1007/s11239-021-02470-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Trahtemberg U, Rottapel R, Dos Santos CC, Slutsky AS, Baker A, Fritzler MJ. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients. Ann Rheum Dis 2021;80:1236-40. [PMID: 33903092 DOI: 10.1136/annrheumdis-2021-220206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]